Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Hydrogel microenvironments for cancer spheroid growth and drug screening.

Li Y, Kumacheva E.

Sci Adv. 2018 Apr 27;4(4):eaas8998. doi: 10.1126/sciadv.aas8998. eCollection 2018 Apr. Review.

2.

Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines.

Avci ME, Keskus AG, Targen S, Isilak ME, Ozturk M, Atalay RC, Adams MM, Konu O.

Sci Rep. 2018 Jan 25;8(1):1570. doi: 10.1038/s41598-018-19817-w.

3.

Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration.

Carneiro MLB, Lopes CAP, Miranda-Vilela AL, Joanitti GA, da Silva ICR, Mortari MR, de Souza AR, Báo SN.

Toxicol Rep. 2015 Jul 17;2:1086-1100. doi: 10.1016/j.toxrep.2015.07.010. eCollection 2015.

4.

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging.

Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Larsimont D, Doumont G, Van Simaeys G, Goldman S, Flamen P, Ghanem G.

Oncotarget. 2017 Apr 10;8(34):56185-56198. doi: 10.18632/oncotarget.17015. eCollection 2017 Aug 22.

5.

The era of bioengineering: how will this affect the next generation of cancer immunotherapy?

Graciotti M, Berti C, Klok HA, Kandalaft L.

J Transl Med. 2017 Jun 19;15(1):142. doi: 10.1186/s12967-017-1244-2. Review.

6.

Therapeutic Hypothesis Testing With Rodent Brain Tumor Models.

Wainwright DA, Horbinski CM, Hashizume R, James CD.

Neurotherapeutics. 2017 Apr;14(2):385-392. doi: 10.1007/s13311-017-0523-1. Review.

7.

The biology of uveal melanoma.

Amaro A, Gangemi R, Piaggio F, Angelini G, Barisione G, Ferrini S, Pfeffer U.

Cancer Metastasis Rev. 2017 Mar;36(1):109-140. doi: 10.1007/s10555-017-9663-3. Review.

8.

Tumorigenicity and Validity of Fluorescence Labelled Mesenchymal and Epithelial Human Oral Cancer Cell Lines in Nude Mice.

Cai WX, Zheng LW, Ma L, Huang HZ, Yu RQ, Zwahlen RA.

Biomed Res Int. 2016;2016:4897986. Epub 2016 Nov 13.

9.

Preclinical screening methods in cancer.

Kumar S, Bajaj S, Bodla RB.

Indian J Pharmacol. 2016 Sep-Oct;48(5):481-486.

10.

Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphate.

Ignat M, Akladios CY, Lindner V, Khetchoumian K, Teletin M, Muttter D, Aprahamian PM, Marescaux J.

J Exp Clin Cancer Res. 2016 Sep 29;35(1):155.

11.

Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma.

Kim KI, Chung HK, Park JH, Lee YJ, Kang JH.

World J Gastroenterol. 2016 Jul 21;22(27):6127-34. doi: 10.3748/wjg.v22.i27.6127. Review.

12.

Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Stei MM, Loeffler KU, Holz FG, Herwig MC.

Biomed Res Int. 2016;2016:4521807. doi: 10.1155/2016/4521807. Epub 2016 Jun 6. Review.

13.

Optimal Design for Informative Protocols in Xenograft Tumor Growth Inhibition Experiments in Mice.

Lestini G, Mentré F, Magni P.

AAPS J. 2016 Sep;18(5):1233-43. doi: 10.1208/s12248-016-9924-z. Epub 2016 Jun 15.

14.

Evaluation of Antitumor Activity of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid in Animal Models of Breast Tumor and Gliosarcoma.

Rocha TG, Lopes SC, Cassali GD, Ferreira Ê, Veloso ES, Leite EA, Braga FC, Ferreira LA, Balvay D, Garofalakis A, Oliveira MC, Tavitian B.

Integr Cancer Ther. 2016 Dec;15(4):512-524. Epub 2016 Apr 29.

15.

Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.

Kozlowska AK, Kaur K, Topchyan P, Jewett A.

Cancer Immunol Immunother. 2016 Jul;65(7):835-45. doi: 10.1007/s00262-016-1822-9. Epub 2016 Mar 31. Review.

16.

Current State of Animal (Mouse) Modeling in Melanoma Research.

Kuzu OF, Nguyen FD, Noory MA, Sharma A.

Cancer Growth Metastasis. 2015 Oct 6;8(Suppl 1):81-94. doi: 10.4137/CGM.S21214. eCollection 2015. Review.

17.

Molecular and clinical implementations of ovarian cancer mouse avatar models.

Zayed AA, Mandrekar SJ, Haluska P.

Chin Clin Oncol. 2015 Sep;4(3):30. doi: 10.3978/j.issn.2304-3865.2015.04.01. Review.

18.

Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.

Min JW, Kim WJ, Han JA, Jung YJ, Kim KT, Park WY, Lee HO, Choi SS.

PLoS One. 2015 Aug 25;10(8):e0135817. doi: 10.1371/journal.pone.0135817. eCollection 2015.

19.

Patient-derived cell models as preclinical tools for genome-directed targeted therapy.

Lee JY, Kim SY, Park C, Kim NK, Jang J, Park K, Yi JH, Hong M, Ahn T, Rath O, Schueler J, Kim ST, Do IG, Lee S, Park SH, Ji YI, Kim D, Park JO, Park YS, Kang WK, Kim KM, Park WY, Lim HY, Lee J.

Oncotarget. 2015 Sep 22;6(28):25619-30. doi: 10.18632/oncotarget.4627.

20.

A better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivo.

Wang H, Li W, Lai B, Yang X, Zhang C, Li J, Zhu Y.

Anticancer Drugs. 2015 Sep;26(8):852-9. doi: 10.1097/CAD.0000000000000259.

Supplemental Content

Support Center